APA (7th ed.) Citation

MJ, L., N, H., CT, T., HJW, F., A, E., & DR, M. (2022). Challenges of rapamycin repurposing as a potential therapeutic candidate for COVID-19: Implications for skeletal muscle metabolic health in older persons. American journal of physiology. Endocrinology and metabolism, 322(6), E551. https://doi.org/10.1152/ajpendo.00064.2022

Chicago Style (17th ed.) Citation

MJ, Lees, Hodson N, Tinline-Goodfellow CT, Fung HJW, Elia A, and Moore DR. "Challenges of Rapamycin Repurposing as a Potential Therapeutic Candidate for COVID-19: Implications for Skeletal Muscle Metabolic Health in Older Persons." American Journal of Physiology. Endocrinology and Metabolism 322, no. 6 (2022): E551. https://doi.org/10.1152/ajpendo.00064.2022.

MLA (9th ed.) Citation

MJ, Lees, et al. "Challenges of Rapamycin Repurposing as a Potential Therapeutic Candidate for COVID-19: Implications for Skeletal Muscle Metabolic Health in Older Persons." American Journal of Physiology. Endocrinology and Metabolism, vol. 322, no. 6, 2022, p. E551, https://doi.org/10.1152/ajpendo.00064.2022.